Regulus Therapeutics Inc. (RGLS)
USD 1.51
(-6.79%)
USD 1.51
(-6.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 10 Million | 6.83 Million | 72 Thousand |
| Cost of Revenue | 21.15 Million | 122 Thousand | 459 Thousand | 15.34 Thousand | 12.34 Thousand | 33.97 Million |
| Gross Profit | -21.15 Million | -122 Thousand | -459 Thousand | 9.99 Million | 6.81 Million | -33.9 Million |
| Operating Expenses | 9.95 Million | 28.23 Million | 27.81 Million | 24.16 Million | 23.66 Million | 46.83 Million |
| Selling, General and Administrative Expenses | 9.95 Million | 9.82 Million | 10.02 Million | 8.81 Million | 11.31 Million | 12.86 Million |
| Research and Development Expenses | 21.15 Million | 18.41 Million | 17.79 Million | 15.34 Million | 12.34 Million | 33.97 Million |
| Other Expenses | -21.15 Million | -83 Thousand | 9000.00 | -1.57 Million | -1.75 Million | -1.88 Million |
| Cost and Expenses | 31.1 Million | 28.23 Million | 27.81 Million | 24.16 Million | 23.66 Million | 46.83 Million |
| Operating Income | -31.1 Million | -28.23 Million | -27.81 Million | -14.15 Million | -16.83 Million | -46.76 Million |
| Interest Expense | 604 Thousand | 688 Thousand | 855 Thousand | 1.8 Million | 2.13 Million | 2.34 Million |
| Income Tax Expense | 1000.00 | 1000.00 | 1000.00 | -467 Thousand | 1000.00 | 62 Thousand |
| Earnings before Tax | -30.03 Million | -28.32 Million | -27.8 Million | -15.73 Million | -18.59 Million | -48.64 Million |
| Net Income | -30.03 Million | -28.32 Million | -27.8 Million | -15.26 Million | -18.59 Million | -48.7 Million |
| Earnings Per Share Basic | -1.58 | -1.86 | -3.24 | -4.36 | -10.77 | -55.87 |
| Earnings Per Share Diluted | -1.58 | -1.86 | -3.24 | -4.36 | -10.77 | -55.87 |
| Weighted Average Shares Outstanding | 18.96 Million | 15.25 Million | 8.57 Million | 3.49 Million | 1.72 Million | 871.85 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 18.96 Million | 15.25 Million | 8.57 Million | 3.49 Million | 1.72 Million | 871.85 Thousand |
| Gross Margin | - | - | - | 1.00 | 1.00 | -470.88 |
| EBIT Margin | - | - | - | -1.41 | -2.46 | -649.49 |
| Profit Margin | - | - | - | -1.53 | -2.72 | -676.51 |
| EBITDA | -30.88 Million | -28.11 Million | -27.35 Million | -13.45 Million | -15.52 Million | -44.04 Million |
| Earnings Before Tax Margin | - | - | - | -1.41 | -2.46 | -649.49 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 302 Thousand | - | - | - |
| Cost of Revenue | 89 Thousand | 81 Thousand | 76 Thousand | 227 Thousand | 56 Thousand | 47 Thousand |
| Gross Profit | -89 Thousand | -81 Thousand | 226 Thousand | -227 Thousand | -56 Thousand | -47 Thousand |
| Operating Expenses | 12.17 Million | 8.82 Million | 8.22 Million | 30.88 Million | 8.12 Million | 7.31 Million |
| Selling, General and Administrative Expenses | 3.93 Million | 2.78 Million | 2.51 Million | - | 2.63 Million | 2.33 Million |
| Research and Development Expenses | 8.24 Million | 6.04 Million | 5.7 Million | - | 5.48 Million | 4.97 Million |
| Other Expenses | -8.3 Million | - | - | - | - | - |
| Cost and Expenses | 12.26 Million | 8.82 Million | 8.3 Million | 31.1 Million | 8.12 Million | 7.31 Million |
| Operating Income | -12.26 Million | -8.82 Million | -8.3 Million | -31.1 Million | -8.12 Million | -7.31 Million |
| Interest Expense | 58 Thousand | -81 Thousand | 114 Thousand | 604 Thousand | -137 Thousand | 168 Thousand |
| Income Tax Expense | 1000.00 | -81 Thousand | 100 Thousand | 1000.00 | -56 Thousand | 1000.00 |
| Earnings before Tax | -11.03 Million | -8.46 Million | -8.06 Million | -30.03 Million | -7.82 Million | -7.01 Million |
| Net Income | -11.03 Million | -8.46 Million | -8.06 Million | -30.03 Million | -7.82 Million | -7.01 Million |
| Earnings Per Share Basic | -0.17 | -0.29 | -0.40 | - | -0.40 | -0.37 |
| Earnings Per Share Diluted | -0.17 | -0.29 | -0.40 | - | -0.40 | -0.37 |
| Weighted Average Shares Outstanding | 64.46 Million | 28.74 Million | 20.22 Million | 18.96 Million | 19.62 Million | 19.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.46 Million | 28.74 Million | 20.22 Million | 18.96 Million | 19.62 Million | 19.1 Million |
| Gross Margin | - | - | 0.75 | - | - | - |
| EBIT Margin | - | - | -27.23 | - | - | - |
| Profit Margin | - | - | -26.69 | - | - | - |
| EBITDA | -12.17 Million | -8.82 Million | -8.22 Million | - | -8.12 Million | -6.79 Million |
| Earnings Before Tax Margin | - | - | -27.48 | - | - | - |
EXMGF
PANTH
4626
605286
6023
SII